Scope Fluidics S.A. is a biotechnology company engaged in designing and developing innovative projects based on microfluidic technologies in medical diagnostics and healthcare.
Scope Fluidics S.A. owns a special-purpose vehicle, Bacteromic Sp. z o.o., established to develop the BacterOMIC system designed to assess the drug susceptibility of microorganisms.
In 2022, Scope Fluidics S.A. sold to Bio-Rad the technology of its proprietary PCR|ONE diagnostic system designed to assess the drug susceptibility of microorganisms as part of its special-purpose vehicle Curiosity Diagnostics Sp. z o.o.
Duchnicka 3/16 Wej. A, 01-796 Warszawa – Poland
Aug. 1, 2017Stock exchange(s)
Warsaw Stock Exchange